Hims House Saad Alam (CEO, Hone Health) - Longevity, testosterone, & peptides
11 snips
Oct 14, 2025 
Saad Alam, Founder and CEO of Hone Health, shares his journey into hormonal health and telehealth. He discusses the innovative services Hone offers, including testosterone therapy and personalized diagnostics. With insights into the future of primary care, he explores the intriguing landscape of peptides and longevity medications. Saad also touches on the effects of social media ad policies on healthcare advertising and expresses optimism about the potential of longevity platforms transforming the industry.
AI Snips
Chapters
Transcript
Episode notes
Younger Users And Environmental Decline
- Hone's average user age (39) is much younger than the national average (52), showing earlier adoption. Environmental estrogenic compounds and aging both reduce testosterone across cohorts.
Personal Longevity Routine And Diagnostics
- Saad uses a hyperbaric chamber, cold plunge, sauna, frequent biomarker panels, full-body MRIs and DNA methylation tests as part of his personal longevity regimen. Hone offers a 50-biomarker test plus a 30–45 minute physician consult for $65.
Be Conservative With Compounded GLP‑1s
- Avoid compounding GLP-1s en masse if you want to limit regulatory and business risk. Favor validated, manufacturer-supplied GLP-1s until the regulatory picture clarifies.